AI Insight: Core Laboratories N.V. (CLB) trades at $10.00, below the PERT-weighted fair value of $16.98, indicating a potential undervaluation with a high confidence level across five valuation methods. Monte Carlo analysis shows notable downside risk (33.3%) and high volatility (47.96% coefficient of variation), reflecting significant uncertainty despite upside potential. Financial health is generally good, though growth scores are modest, suggesting balance between income stability and limited expansion.